Ischemic and Hemorrhagic STROKE Treatments
Extending the Treatment Window
The BiPlane Angiography System in the Silver Cross Neuro Endovascular Lab allows specialists the treatment window to stop a stroke and even reverse its effect.
The team of physicians at the Silver Cross Neuroscience Institute use FDA-approved interventions that could significantly improve the treatment window.
0-4.3 Hours from Symptom Onset
Administration of the thrombolytic agent t-PA intravenously to treat people with acute ischemic stroke.
0-6 Hours from Symptom Onset
In the neuro-endovascular suite, t-PA is administered through a catheter injected into the artery instead of the vein up to six hours from the symptom onset.
Mechanical clot remover with the Penumbra aspiration system or stent retriever device
The Penumbra system is a neuroembolectomy device specifically designed to remove thrombosis through a system of reperfusion catheters and separators to facilitate direct aspiration. The device works by suction of the thrombus along with clot disruption. Stent retrievers can retrieve a clot without permanent stent placement. They act as a temporary bypass providing immediate flow restoration through the thrombus and as a clot retriever trapping thrombus within the struts of the stent.
Advanced Treatments for HEMORRHAGIC STROKES
The Silver Cross Neuroscience Institute offers minimally invasive procedures for treating aneurysms and hemorrhagic strokes. Our advanced diagnostic capabilities, including 3D angiograms, allow neuro interventional radiologists to locate cerebral aneurysms and accurately determine the best approach including:
• Platinum coiling for narrow-neck aneurysms
• Stent assisted large-neck aneurysms
• Glue embolizaton for arterial venous malformation (AVM)
• ONYX injection for AVM
• PVA particles for tumor embolization and epistaxis.